FeesSafety
Pluang+

FDA approves Haemonetics' PerQseal Elite for large-bore arterial closure in the U.S.

Market News
19 Oct 2026, 23:15 WIB
PRNewsWire
View Source
Bullish
FDA approves Haemonetics' PerQseal Elite for large-bore arterial closure in the U.S.

Haemonetics Corporation announced FDA approval for its PerQseal Elite vascular closure system, designed for large-bore arterial procedures using 14-22F sheaths. This sutureless, bioabsorbable patch device offers near-instantaneous hemostasis and leaves no permanent implant, improving patient outcomes and procedural efficiency. The approval follows positive clinical trial results showing zero major complications and a hemostasis time under one minute. Haemonetics plans to present further clinical data at the upcoming TCT Conference, aiming to expand its presence in advanced vascular closure technologies in the U.S.

Haemonetics' FDA approval of the PerQseal Elite vascular closure system provides context for readers interested in medical technology advancements. For readers following the Health sector, here is Pluang's market snapshot as of Oct 20, 2026 03:02 WIB: out of 150 priced Health-sector US stocks, 87 rose and 62 fell. Notable movers include SYRE (Spyre Therapeutics Inc.) at USD 85.02 with a 6.41% increase, TWST (Twist Bioscience Corp) at USD 140.34 with a 5.72% rise and 100% buy order activity, and SLS (SELLAS Life Sciences Group Inc.) at USD 10.50 with a 5.21% gain.

More News

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs predicts the S&P 500 will climb about 26% to 8,700 points within the next 12 months, despite recent market volatility and concerns over AI-driven tech investments. The forecast is supported by lower valuations in tech stocks and a forwa...

Bullish
1 hour ago
S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

Over the past decade, the S&P 500 index has risen 229%, turning a $1,000 investment into nearly $4,000, mainly due to a 212% increase in corporate earnings rather than valuation changes. Despite recent market drops and volatility, holding through pul...

Bullish
1 hour ago
Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb, a major pharmaceutical company, currently offers a 4.3% dividend yield and trades at a price-to-earnings ratio well below the industry average. Its newer drug portfolio generated nearly $7.7 billion in revenue last quarter, grow...

Market News
Bullish
1 hour ago
Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia's stock has dropped about 43% following CEO Jensen Huang's sudden resignation linked to alleged Chinese intelligence ties, wiping out over $2.5 trillion in market value. Despite concerns about leadership loss, analyst Dan Ives believes Nvidia'...

Market News
Bearish
1 hour ago
ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS has announced a holiday sale offering discounts up to 44% on a wide range of laptops and desktops, available online and in stores like Best Buy until December 2, 2026. The sale features budget-friendly options like the ASUS Vivobook 14 starting ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App